1

NEU

06.23.2020

Related Articles

Global Pharma Market Access: Pharmacoeconomics in Middle-income Countries

Introduction Many middle-income countries such as Egypt, South Africa, Malaysia, Thailand, and Brazil have pharmacoeconomic guidelines. These follow the recommendations by the International Society for Pharmacoeconomics and Outcomes Research but include country-specific differences. The variations respond to changes in how governments apply pharmacoeconomics and determine market access to pharmaceuticals and medical devices. This is also […]

Read all
Together for Access to Innovative Treatments.

Panel Theme “Together for Access to Innovative Treatments.” 20 June 2022. Organizer Todos Juntos Contra on Cancer (TJCC). TJCC is composed of more than 200 institutions from different sectors engaged in improving cancer care in Brazil and aims to improve policies for Oncology. https://tjcc.com.br/ Panelists Prof. João L. Carapinha Dr. Antonio Carlos Buzaid Dr. José […]

Read all
Value-Based Pricing of New Healthcare Technologies

What is value-based pricing of new healthcare technologies? Value-based pricing aims to reward pharmaceutical companies and medical device companies for investments in new healthcare technologies that result in sustained improvements in patient quality of life. We also expect such technologies to deliver measurable net economic benefits for society. In economic theory, value-based pricing is when […]

Read all
Read all articles